Analysis Sets Sample Clauses

Analysis Sets. Five analysis sets will be defined: a) All Enrolled – all subjects signing the informed consent form b) Enrolled Dispensed – subjects/eyes from All Enrolled that have been exposed to study lenses c) Enrolled Not Dispensed – subjects/eyes from All Enrolled that have not been exposed to study lenses d) Completed – Enrolled Dispensed subjects/eyes completing the study e) Discontinued – Enrolled Dispensed subjects/eyes not complete the study
Sample 1
AutoNDA by SimpleDocs
Analysis Sets. All analysis sets will be defined prior to final database closure. In addition to the analysis sets listed below, further exploratory analyses may be performed using other subgroups of patients.
Sample 1
Analysis Sets. The analysis populations are as follows: • The primary analysis population is the modified intent-to-treat (mITT) population, which will include all randomized subjects who received at least 1 dose of study drug and have baseline and at least 1 post-baseline virology measurement. The primary analysis will also be performed on the per-protocol population of patients who completed treatment without a major protocol deviation. • The PK population will include subjects who receive at least 1 dose of the study drug and have sufficient concentration data to support accurate estimation of at least 1 PK parameter. • The safety population will include all subjects who receive at least 1 dose of study drug. • A per protocol population will include the subset of the modified intent-to-treat population who completed study drug treatment without a major protocol violation.
Sample 1
Analysis Sets. The set of randomized patients will include all patients randomly assigned to a treatment at enrollment, regardless of whether or not a patient took any study drug. The safety analysis set will include all patients who took at least 1 dose of study drug. The full analysis set will include all patients in the safety analysis set.
Sample 1
Analysis Sets. Five analysis sets will be defined: a) All Enrolled – all subjects signing the informed consent form b) Enrolled Dispensed – subjects/eyes from All Enrolled that have been exposed to study lenses (not considering trial-fit lenses prior to randomization) c) Enrolled Not Dispensed – subjects/eyes from All Enrolled that have not been exposed to study lenses (not considering trial-fit lenses prior to randomization) d) Completed – Enrolled Dispensed subjects/eyes completing the study e) Discontinued – Enrolled Dispensed subjects/eyes not complete the study
Sample 1
Analysis Sets. Analysis datasets used for safety and effectiveness analyses of this study are defined as follows. The treatment-emergent safety analysis set will include all eyes with attempted implantation with the test article (successful or aborted after contact with the eye). All-Implanted Analysis Set (AAS) will include all eyes with successful test article implantation. Best-Case Analysis Set (BAS) will include all eyes with successful test article implantation that had ・ at least 1 postoperative visit; ・ no macular degeneration at any time; and ・ no major protocol violation
Sample 1
Analysis Sets. 2.1 Definition of analysis sets 2.1.1 Intention to treat (ITT)
Sample 1
AutoNDA by SimpleDocs
Analysis Sets. There will be one analysis population, the Safety set, which includes all patients who are enrolled in the study and receive at least 1 dose of eteplirsen.
Sample 1

Related to Analysis Sets

  • Analysis An analysis of the types, quantity, and availability of labor required to perform all of the Work;

  • Investment Analysis and Implementation In carrying out its obligations under Section 1 hereof, the Advisor shall: (a) supervise all aspects of the operations of the Funds; (b) obtain and evaluate pertinent information about significant developments and economic, statistical and financial data, domestic, foreign or otherwise, whether affecting the economy generally or the Funds, and whether concerning the individual issuers whose securities are included in the assets of the Funds or the activities in which such issuers engage, or with respect to securities which the Advisor considers desirable for inclusion in the Funds' assets; (c) determine which issuers and securities shall be represented in the Funds' investment portfolios and regularly report thereon to the Board of Trustees; (d) formulate and implement continuing programs for the purchases and sales of the securities of such issuers and regularly report thereon to the Board of Trustees; and (e) take, on behalf of the Trust and the Funds, all actions which appear to the Trust and the Funds necessary to carry into effect such purchase and sale programs and supervisory functions as aforesaid, including but not limited to the placing of orders for the purchase and sale of securities for the Funds.

  • ANALYSIS AND MONITORING The Custodian shall (a) provide the Fund (or its duly-authorized investment manager or investment adviser) with an analysis of the custody risks associated with maintaining assets with the Eligible Securities Depositories set forth on Schedule B hereto in accordance with section (a)(1)(i)(A) of Rule 17f-7, and (b) monitor such risks on a continuing basis, and promptly notify the Fund (or its duly-authorized investment manager or investment adviser) of any material change in such risks, in accordance with section (a)(1)(i)(B) of Rule 17f-7.

  • Statistical Sampling Documentation a. A copy of the printout of the random numbers generated by the “Random Numbers” function of the statistical sampling software used by the IRO.‌ b. A description or identification of the statistical sampling software package used by the IRO.‌

  • Fundamental Analysis The equity investment analysts provide independent research and analysis of specific companies within a sector. Typically, analysis includes review of published reports, interviews of company management, on-site observation of company operations, and the use of various financial models. In addition, analysts read trade journals, attend industry conferences, and focus on trends within the sector and industry. Based on this proprietary analysis, the analyst makes buy, sell or hold recommendations to the Adviser.

  • Investment Analysis and Commentary The Subadviser will provide quarterly performance analysis and market commentary (the “Investment Report”) during the term of this Agreement. The Investment Reports are due within 10 days after the end of each quarter. In addition, interim Investment Reports shall be issued at such times as may be mutually agreed upon by the Adviser and Subadviser; provided however, that any such interim Investment Report will be due within 10 days of the end of the month in which such agreement is reached between the Adviser and Subadviser. The subject of each Investment Report shall be mutually agreed upon. The Adviser is freely able to publicly distribute the Investment Report.

  • Independent Analysis Each Party hereby confirms that its decision to execute this Agreement has been based upon its independent assessment of documents and information available to it, as it has deemed appropriate.

  • Sampling The Licensee agrees that the Composition is purchased as a “Work Made for Hire” whereby the clearing of any sampled materials is the responsibility of Licensee.

  • TRUNK FORECASTING 57.1. CLEC shall provide forecasts for traffic utilization over trunk groups. Orders for trunks that exceed forecasted quantities for forecasted locations will be accommodated as facilities and/or equipment are available. Sprint shall make all reasonable efforts and cooperate in good faith to develop alternative solutions to accommodate orders when facilities are not available. Company forecast information must be provided by CLEC to Sprint twice a year. The initial trunk forecast meeting should take place soon after the first implementation meeting. A forecast should be provided at or prior to the first implementation meeting. The semi-annual forecasts shall project trunk gain/loss on a monthly basis for the forecast period, and shall include: 57.1.1. Semi-annual forecasted trunk quantities (which include baseline data that reflect actual Tandem and end office Local Interconnection and meet point trunks and Tandem-subtending Local Interconnection end office equivalent trunk requirements) for no more than two years (current plus one year); 57.1.2. The use of Common Language Location Identifier (CLLI-MSG), which are described in Telcordia documents BR 000-000-000 and BR 000-000-000; 57.1.3. Description of major network projects that affect the other Party will be provided in the semi-annual forecasts. Major network projects include but are not limited to trunking or network rearrangements, shifts in anticipated traffic patterns, or other activities by CLEC that are reflected by a significant increase or decrease in trunking demand for the following forecasting period. 57.1.4. Parties shall meet to review and reconcile the forecasts if forecasts vary significantly.

  • Risk Analysis The Custodian will provide the Fund with a Risk Analysis with respect to Securities Depositories operating in the countries listed in Appendix B. If the Custodian is unable to provide a Risk Analysis with respect to a particular Securities Depository, it will notify the Fund. If a new Securities Depository commences operation in one of the Appendix B countries, the Custodian will provide the Fund with a Risk Analysis in a reasonably practicable time after such Securities Depository becomes operational. If a new country is added to Appendix B, the Custodian will provide the Fund with a Risk Analysis with respect to each Securities Depository in that country within a reasonably practicable time after the addition of the country to Appendix B.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!